Discontinuation report TRIZIVIR
| Report ID | 94278 |
| Drug Identification Number | 02244757 |
| Brand name | TRIZIVIR |
| Common or Proper name | abacavir (as abacavir sulfate), lamivudine and zidovudine tablets |
| Company Name | VIIV HEALTHCARE ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ZIDOVUDINE ABACAVIR LAMIVUDINE |
| Strength(s) | 300MG 300MG 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 60's |
| ATC code | J05AR |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2019-09-17 |
| Remaining supply date | 2020-06-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-877-393-8448 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2019-09-18 | French | Compare |
| v1 | 2019-09-18 | English | Compare |
Showing 1 to 2 of 2